Update on July 3-5 EACPT Cardiovascular Focus Meeting in the Netherlands

Following the well-attended EACPT international summer school in 2013 in Edinburgh, the next European Association for Clinical Pharmacology and Therapeutics [EACPT] update for young researchers is the 2014 EACPT Focus Meeting on 'Drugs to Fight Cardiovascular Damage'. The EACPT Focus Meeting will provide you with the opportunity to attend state of the art lectures from leading professionals and researchers, including hands-on workshops. 
Topics include ultrasound imaging of vascular injury (including a hands-on workshop), the microbiome and inflammation in the metabolic syndrome, targeting inflammation to prevent and treat atherosclerosis, diagnosis and therapy of adrenal hypertension, and protection against ischaemia-reperfusion injury.

This EACPT Cardiovascular Focus Meeting is of interest to clinical pharmacologists, pharmacologists, and other young scientists and clinicians interested in drug treatment of cardiovascular disease. You can listen here to podcasts with international delegates at the last EACPT summer meeting in Edinburgh in 2013.

The abstract deadline is April 15th - the top 5 ranked abstracts will be provided with free registration. Abstract submission is online on the Focus Meeting website. There are opportunities for both oral and poster presentations within the overall scientific program.  All abstracts presented at the meeting will be published in Clinical Therapeutics, the peer-reviewed Official Journal of the EACPT. 

Registration is now open - with preferential rates if you register by May 15th. A preferential accommodation rate is available through the Focus Meeting website.

The Scientific Programme is now online on the Focus Meeting website. The 2014 EACPT Focus Meeting takes place from July 3rd - 5th at the Radboud University Medical 

Radboud University Medical Centre, Nijmegen

Center in Nijmegen in the Netherlands. 
Visit the Clinical Therapeutics website.

Save the dates for the 12th EACPT Congress in Madrid - 27-30 June, 2015

Madrid will be the hosting city for the 12th Congress of the European

Habsburg period Plaza Mayor, Madrid

Association for Clinical Pharmacology and Therapeutics. It is the first time the EACPT Congress will take place in Spain, following previous presentations of bids for Barcelona 2009 and Valencia 2013.  Although it took some time for the EACPT to accommodate Spain’s enthusiasm to receive the European and Worldwide CPT community, we are delighted that this will finally be a reality in 2015.

EACPT and SEFC will give you the best of themselves to make of this a memorable EACPT conference. Keeping the essence of EACPT meetings, we will aim to make an innovative and attractive program for you all in general, and for young clinical pharmacologists in particular.

EACPT Congresses already attract a worldwide audience. We aim to have relevant contributions from our Portuguese and Latin American colleagues to give this meeting a special intercontinental flavour.

Save the date! The EACPT 12th Congress will take place on 27-30 June 2015, at the Hotel Meliá Castilla, in the heart of Madrid.

The complete scientific program will be released during May this year. The meeting website will be available during March. It will include all important information on the congress, including meeting timelines, registration and accommodation.

SEE YOU ALL IN MADRID!

The official journal of the EACPT is Clinical Therapeutics 

 

Register interest in the EACPT

The EACPT is planning to launch Individual EACPT Associates as a new opportunity to become part of the EACPT and to support its activities. Benefits for Individual EACPT Associates will include

• online access to our official journal – Clinical Therapeutics
• 50% reduction in page charges for publishing in the journal
• involvement in EACPT working groups and other EACPT activities
• opportunities to become involved in partner activities between the EACPT and other organisations

The Individual EACPT Associates initiative will be launched in the Spring of 2014.

2014 EACPT Focus Meeting: 'Drugs to Fight Cardiovascular Damage' 3-5 July, 2014

Following the well-attended EACPT international summer school in 2013 in Edinburgh, the next European Association for Clinical Pharmacology and Therapeutics [EACPT] update for young researchers is the 2014 EACPT Focus Meeting on  'Drugs to Fight Cardiovascular Damage'.

The 2014 EACPT Focus Meeting takes place from July 3rd - 5th at the Radboud University Medical

Radboud University Medical Centre, Nijmegen

Center in Nijmegen in the Netherlands. 

This EACPT cardiovascular focus meeting is of interest to clinical pharmacologists, pharmacologists, and other young scientists and clinicians interested in drug treatment of cardiovascular disease. 

Topics include: 
- ultrasound imaging of vascular injury (including a workshop tproviding t hands-on training),
- the microbiome and inflammation in the metabolic syndrome
- targeting inflammation to prevent and treat atherosclerosis
- diagnosis and therapy of adrenal hypertension
- protection against ischaemia-reperfusion injury. 

Provisional State of the Art Lectures by invited speakers include:

Arterial stiffness measurements; methods and relevance for risk assessment and drug-research: Stephane Laurent, Paris, France

IMT measurement with ultrasound, methods and relevance for risk assessment and drug research: Luc van Bortel, Gent, Belgium

The microbiome in the pathogenesis of metabolic syndrome: Max Nieuwdorp

Fat cells and inflammation in the pathogenesis of the Metabolic Syndrome: Rinke Stienstra, Nijmegen, The Netherlands

Predicting and manipulating drug inactivation by the human gut microbiome: H. Haiser. FAS Center for Systems Biology, Harvard University, USA

Cardiac protection by conditioning: from bench to bedside: D. Hausenloy, Hatter Institute, London

The role of hexokinase in cardioprotection: C. Zuurbier, Amsterdam, The Netherlands

Wnt pathways in cardiac repair and remodeling: M. Blankesteijn

Targeting the adaptive immune system in atherosclerosis: Esther Lutgens, AMC, Amsterdam

Trained immunity in the pathogenesis of atherosclerosis: Niels Riksen, Nijmegen, The Netherlands

The pathogenesis of autonomous adrenal aldosterone release: Felix Beuschlein

Diagnosis and treatment of hyperaldosteronism: Jaap Deinum, Nijmegen, The Netherlands

Health professional scientists, academics and  professionals from the pharmaceutical, biotechnology, and related sectors are invited to submit their latest scientific results for oral or poster presentation.

For more information, email  eacpt2014@kenes.com.

Abstract submission and registration will open shortly on our dedicated website.

Abstracts will be published online in Clinical Therapeutics, the Official Journal of the EACPT.

Update from London on the EACPT

The Executive Committee of the European Association for Clinical Pharmacology and Therapeutics (EACPT) met in London 12-13 October, hosted by the British
Pharmacological Society. The main business of this EC meeting was planning for major pending events and activities. Key items included:

Members of the EACPT Executive Committee

the 12th biennial EACPT congress to be held from 27-29 June 2015 in Madrid 
- the EACPT focus meeting in Nijmegen in the Netherlands, 3-5 July 2014 - the key theme is cardiovascular.
- update on the official EACPT journal Clinical Therapeutics (online access is a benefit for individual Associates of the EACPT - see register interest link below) 
- interaction with key policy organisations interested in medicines and patient safety, including the European Medicines Agency. EACPT chair Professor Gonzalo Calvo is inaugural co-chair of the Healthcare Professionals Working Party of the 

European Medicines Agency. 

The above photo, taking at the British Pharmacological Society offices, shows: 

Back row: Dinko Vitezić (Croatia), Simon Maxwell (UK), Donald Singer (UK), Ingolf Cascorbi (Germany), Ádám Vas (Hungary), Gerard Rongen (Netherlands) 

Front row: Gonzalo Calvo (Spain), Caridad Pontes (Spain), Marie Besson (Geneva), Ylva Böttiger (Sweden),  Caroline Samer (Geneva). 

Also at the meeting were Professor Kim Brosen (Denmark) and EACPT Chair-elect Professor Tabassome Simon (France).

Parliament buildings and former County Hall

EACPT biennial congresses provide excellent opportunities to showcase issues of topical international concern to the CPT community, through timely and accessible original research presentations and commentaries to policy-makers, health and industry professionals, health technology providers, patient groups and academia. 

The Madrid 2015 Congress will bring together a wide range of international delegates, including health professionals, clinical and life scientists, policy makers, professionals from the biotechnology and pharmaceutical communities and others interested in the spectrum from basic to clinical pharmacology and pharmacotherapy, and from drug discovery to regulatory affairs. 

Co-organisers Marie Besson and Caroline Samer reported on the recent Geneva EACPT Congress. Almost 600 delegates attended the 11th EACPT Congress in Geneva in August 2013, where there were 101 invited speakers from 21 countries - 15 countries from the European region and a further 6 countries internationally, from the USA, Canada, New Zealand, China, Benin and India. 330 abstracts were presented as oral and poster communications, following submissions from 57 countries from all 5 continents.

EACPT EC members Caridad Pontes (Spain), Adam Vaz (Hungary), Marie Besson (Switzerland) and Gonzalo Calvo (EACPT Chair: Spain) are members of the organizing committee for the 2015 EACPT Congress in Madrid. 

Key themes at the Madrid congress will include translational medicine and pharmacogenetics, advances in personalised diagnostics to improve the safety and effectiveness of medicines, updates on new biological approaches to disease, therapeutics of cardiovascular, cancer and inflammatory disease, clinical trial design and regulation, drug safety and toxicology, clinical trial design and governance, health policy and safe prescribing.

Register below interest in becoming an individual Associate of the EACPT and in future EACPT activities. 

EMA health professional working party elects EACPT's Gonzalo Calvo as its first co-chair

Gonzalo Calvo, chair of the European Association for Clinical Pharmacology and Therapeutics (EACPT), is the new co-chair of the HCPWP of the European Medicines Agency. 

Professor Calvo is a consultant in clinical pharmacology in Barcelona and has extensive experience both in medicines regulation, including nearly ten years as member of the Agency’s Committee for Medicinal Products for Human Use (CHMP), and in learned societies. This is the first time that the HCPWP has elected a co-chair, following its formal establishment in June 2013.  

The Patients' and Consumers' Working Party (PCWP) and the Healthcare Professionals' Working Party (HCPWP) of the European Medicines Agency (EMA) both elected their new co-chairs on 26th September, 2013.

David Haerry of the European AIDS TreatmentGroup (EATG) is the new co-chair of the PCWP. He has 15 years experience as an advocate for HIV patients’ rights and has been a member of the PCWP since 2006. He will replace Lise Murphy of the European Organisation for Rare Diseases (EURORDIS), who was co-chair of the PCWP since 2010 and whose mandate has come to an end. The PCWP was established in 2005.

Both David Haerry and Gonzalo Calvo will co-chair these working parties for the next three years, together with Isabelle Moulon, Head of Patients and Healthcare Professionals at the EMA.

The main role of the PCWP and the HCPWP is to provide recommendations to the EMA and its scientific committees on all matters of interest to either patients and consumers or healthcare professionals in relation to medicinal products, as well as to monitor interactions between the Agency and patients, consumers and healthcare professionals.

EACPT Executive Committee members Professor Donald Singer from the UK and Professor Ingolf Cascorbi from Germany are also members of the EMA Health Care Professionals Working Party.

Professor Simon Maxwell, co-chair of the EACPT Educational Subcommittee, is observer on behalf of the HCP-WP on the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCPeP).

New European Medicines Agency advice on black triangle prompts for medicines monitoring

See full EMA Press Release

Adverse reactions to drugs and vaccine are common and may be serious, with the risk of leading to hospital admission, delayed discharge from hospital or death. It has been estimated that up to two-thirds of the ADRs may be preventable, or interrupted before they become severe. 

The European Medicines Agency (see press release link above) has introduced a new EU-wide scheme to improve reporting and prevention of new, unexpected and serious adverse reactions to drugs and vaccines. The scheme involves increased monitoring, including supported by a list of products identified by an inverted black triangle symbol: typically for products that are new, or have had a new indication or formulation approved, or for which serious concerns have been raised.

Communication materials on additional monitoring and the inverted black triangle symbol have been produced in all EU languages. For further details see the factsheet and video below and the EMA Press Release.

Factsheet

Video in English (with subtitles in all official EU languages)

To view subtitles, click on 'captions' at the foot of the viewing pane and select your language. You can also turn subtitles on and off and change the way they appear.

Video in English